Compile Data Set for Download or QSAR
Report error Found 149 Enz. Inhib. hit(s) with Target = 'RNA-directed RNA polymerase L'
TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568402(US11420976, Example 19)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568403(US11420976, Example 20)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568400(US11420976, Example 17)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568401(US11420976, Example 18)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568406(US11420976, Example 23)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568407(US11420976, Example 24)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568404(US11420976, Example 21)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568405(US11420976, Example 22)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568410(US11420976, Example 27)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568411(US11420976, Example 28)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568408(US11420976, Example 25)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568409(US11420976, Example 26)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568414(US11420976, Example 31)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568415(US11420976, Example 32)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568412(US11420976, Example 29)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568413(US11420976, Example 30)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568386(US11420976, Example 3)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568387(US11420976, Example 4)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568384(US11420976, Example 1)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568385(US11420976, Example 2)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568390(US11420976, Example 7)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568391(US11420976, Example 8)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568388(US11420976, Example 5)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568389(US11420976, Example 6)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568394(US11420976, Example 11)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568395(US11420976, Example 12)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568392(US11420976, Example 9)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568393(US11420976, Example 10)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568398(US11420976, Example 15)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568399(US11420976, Example 16)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568396(US11420976, Example 13)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568397(US11420976, Example 14)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568434(US11420976, Example 51)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568435(2-amino-N ((S)-2-((R)-3-amino-7-(4-fluorophenyl)-3...)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568432(US11420976, Example 49)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568433(US11420976, Example 50)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568438(US11420976, Example 55)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568439(US11420976, Example 55c)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568436(US11420976, Example 53)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568437(US11420976, Example 54)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568442(US11420976, Example 57)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568443(US11420976, Example 58)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568440(US11420976, Example 55d)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568441(US11420976, Example 56)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568446(US11420976, Example 59c)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568447(US11420976, Example 59d)
Affinity DataEC50: <200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568444(US11420976, Example 59)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568445(US11420976, Example 59b)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568418(US11420976, Example 35)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

TargetRNA-directed RNA polymerase L(Human respiratory syncytial virus A (strain A2))
Enanta Pharmaceuticals

US Patent
LigandPNGBDBM568419(US11420976, Example 36)
Affinity DataEC50: >200nMAssay Description:Hep-2 cells, (originally derived from tumors grown in irradiated-cortisonised weanling rats that had been injected with epidermoid carcinoma tissue f...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/6/2022
Entry Details
US Patent

Displayed 1 to 50 (of 149 total ) | Next | Last >>
Jump to: